In Vitro Activity of Isavuconazole against Rasamsonia Species

about

Isavuconazole: is there a need for a new antifungal?Systemic Rasamsonia piperina infection in a German shepherd cross dog.Notes for genera: Ascomycota

P2860

Q40273512-A4C3B23B-937C-4453-99C3-A879BC230AAF Q46251456-2A55A16D-08A4-4147-9215-150CDFDA0E0F Q55886027-2E2C5FF4-B6A1-4C9C-9BAE-AF477CC7E09B

P2860

In Vitro Activity of Isavuconazole against Rasamsonia Species

Item

http://www.wikidata.org/entity/Q36104417

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

In Vitro Activity of Isavuconazole against Rasamsonia Species

@ast

In Vitro Activity of Isavuconazole against Rasamsonia Species

@en

type

Item

label

In Vitro Activity of Isavuconazole against Rasamsonia Species

@ast

In Vitro Activity of Isavuconazole against Rasamsonia Species

@en

prefLabel

In Vitro Activity of Isavuconazole against Rasamsonia Species

@ast

In Vitro Activity of Isavuconazole against Rasamsonia Species

@en

P1476

In Vitro Activity of Isavuconazole against Rasamsonia Species

@en

P2093

J Buer

http://www.w3.org/2001/XMLSchema#string

J Houbraken

http://www.w3.org/2001/XMLSchema#string

J Steinmann

http://www.w3.org/2001/XMLSchema#string

P-M Rath

http://www.w3.org/2001/XMLSchema#string

S Dittmer

http://www.w3.org/2001/XMLSchema#string

P2860

Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent

Taxonomy and antifungal susceptibility of clinically important Rasamsonia species.

Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species

Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients

Rasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance.

Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.

Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis.

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.

P304

6890-6891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00742-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27527087

http://www.w3.org/2001/XMLSchema#string

P932

5075100

http://www.w3.org/2001/XMLSchema#string

In Vitro Activity of Isavuconazole against Rasamsonia Species

about

P2860

P2860

In Vitro Activity of Isavuconazole against Rasamsonia Species

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932